Avastin (Bevacizumab) in Combination With ABVD for the Treatment of Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 02 May 2017
At a glance
- Drugs Bevacizumab (Primary) ; Bleomycin; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 17 Mar 2017 Planned End Date changed from 1 Dec 2017 to 1 Nov 2017.
- 17 Mar 2017 Status changed from active, no longer recruiting to discontinued.
- 17 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.